Veronica Siljehav | Karolinska Institutet

About me
Publications
Grants
CV
Public outreach and news

About me

Veronica Siljehav, MD, PhD, is a pediatric cardiology and neonatology subspecialist at Karolinska University Hospital and a postdoctoral researcher at Karolinska Institutet. Her research focuses on neurodevelopmental outcomes in children with congenital heart disease.
Awards
2025: Best Oral Presentation, Association for European Paediatric and Congenital Cardiology (AEPC), Hamburg
2024: Young Investigator Award, Acta Paediatrica
Professional appointments
2026–present: Board Member and Chair, Swedish Pediatric Cardiology Society
2025–present: Pediatric Cardiology Expert, SKR's National Program Area for Children and Adolescents
2025–present: Steering Committee Member, SWEDCON National Registry
2024–2026: Board Member and Secretary, Swedish Pediatric Cardiology Society
2023–present: Member, SWEDCON Working Group

Research

Main interest in longterm outcome on children born preterm or with congenital heart disease.

Teaching

Current
Course director for the doctoral course "Early Child Development: Extended Interactions Between Neural Networks, Body and Environment"
Main supervisor for PhD student Sofia Larsson
Main supervisor for medical students' degree projects
Mentor at the Programme in Medicine
Previous
Coordinator of the seminar series at the Department of Women's and Children's Health, in collaboration with Astrid Lindgren Children's Hospital (2022–2026)
Teacher, Programme in Midwifery, Karolinska Institutet — neonatal resuscitation
Lecturer, Programme in Medicine, Karolinska Institutet — elective course in perinatology

Articles

Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2026;15(13):e049927
Academic Achievements in Adolescents With Congenital Heart Disease: A Total Population-Based Cohort Study
Ekmark Sergel S; Lundberg M; Magnusson C; Aden U; Bergman G; Siljehav V
Article: BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2026;133(4):649-659
Five-Minute Apgar Scores and Its Prognostic Value for Mortality and Severe Morbidity in Very Preterm Infants: A Multinational Cohort Study
Ehrhardt H; Behboodi S; Maier RF; Aubert AM; Aden U; Draper ES; Gudmundsdottir A; Siljehav V; Varendi H; Weber T; Zemlin M; Zeitlin J
Article: JAMA NETWORK OPEN. 2026;9(2):e2557913
Apgar Score Plus Umbilical Artery pH and Adverse Neonatal Outcomes in Very Preterm Infants
Ehrhardt H; Behboodi S; Maier RF; Aubert AM; Aden U; Staude B; Draper ES; Gudmundsdottir A; Siljehav V; Varendi H; Weber T; Zemlin M; Zeitlin J
Article: PEDIATRIC RESEARCH. 2026;:1-8
Economic costs at age five for very preterm children with congenital anomalies: evidence from a European cohort
Kim SW; Siljehav V; Seppanen A-V; Maier RF; Varendi H; Draper E; Andronis L; Cuttini M; Zeitlin J; Petrou S
Article: PEDIATRIC RESEARCH. 2025;97(5):1711-1721
Health-related quality of life at 5 years of age for children born very preterm with congenital anomalies: a multi-national cohort study
Kim SW; Tian X; Andronis L; Maier RF; Varendi H; Seppanen A-V; Siljehav V; Draper ES; Zeitlin J; Petrou S; SHIPS Res Grp J
Article: BMC PEDIATRICS. 2024;24(1):369
The early educational environment at five years of age in a European cohort of children born very preterm: challenges and opportunities for research
Smith-Longee A; Johnson S; Aubert AM; Seppanen A-V; Pierrat V; Zemlin M; Lebeer J; Sarrechia I; Siljehav V; Zeitlin J; Sentenac M
Article: ACTA PAEDIATRICA. 2024;113(3):461-470
Treating very preterm European infants with inhaled nitric oxide increased in-hospital mortality but did not affect neurodevelopment at 5 years of age
Siljehav V; Gudmundsdottir A; Tjerkaski J; Aubert AM; Cuttini M; Koopman C; Maier RF; Zeitlin J; Aden U
Article: FRONTIERS IN PEDIATRICS. 2022;10:921444
The cerebrospinal fluid proteome of preterm infants predicts neurodevelopmental outcome
Leifsdottir K; Jost K; Siljehav V; Thelin EP; Lassaren P; Nilsson P; Haraldsson A; Eksborg S; Herlenius E
Article: ACTA PAEDIATRICA. 2022;111(5):961-970
Proteomic profiles in cerebrospinal fluid predicted death and disability in term infants with perinatal asphyxia: A pilot study
Leifsdottir K; Thelin EP; Lassaren P; Siljehav V; Nilsson P; Eksborg S; Herlenius E
Article: JOURNAL OF PEDIATRICS. 2015;167(6):1207-13.e3
Prostaglandin E₂ Mediates Cardiorespiratory Disturbances during Infection in Neonates
Siljehav V; Hofstetter AM; Leifsdottir K; Herlenius E
Article: JOURNAL OF APPLIED PHYSIOLOGY. 2014;117(9):1027-1036
Il-1β and prostaglandin E₂ attenuate the hypercapnic as well as the hypoxic respiratory response via prostaglandin E receptor type 3 in neonatal mice
Siljehav V; Shvarev Y; Herlenius E
Article: PEDIATRIC RESEARCH. 2012;72(5):460-467
mPGES-1 and prostaglandin E₂: vital role in inflammation, hypoxic response, and survival
Siljehav V; Hofstetter AO; Jakobsson P-J; Herlenius E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2007;104(23):9894-9899
The induced prostaglandin E₂ pathway is a key regulator of the respiratory response to infection and hypoxia in neonates
Hofstetter AO; Saha S; Siljehav V; Jakobsson P-J; Herlenius E

All other publications

Preprint: MEDRXIV. 2026
Academic Achievements in Adolescents with Congenital Heart Disease: A Total Population-Based Cohort Study
Ekmark-Sergel S; Lundberg M; Magnusson C; Ådén U; Bergman G; Siljehav V
Preprint: ARXIV. 2017
Large Neural Network Based Detection of Apnea, Bradycardia and Desaturation Events
Honoré A; Siljehav V; Chatterjee S; Herlenius E
Doctoral thesis: 2014
Neonatal respiratory control : inspiration, inflammation and the prostaglandin E2 pathway
Siljehav V
Book chapter: NEONATOLOGI. p. 267-276
Cirkulationsproblem
Ådén U

Grants

Hjärta och hjärna i samspel – att förstå och stärka utvecklingen hos barn med medfödda hjärtfel
Norrbacka Eugeniastiftelsen
17 September 2026
Sällskapet Barnavård
1 May 2026
Stiftelsen Sunnerdahls Handikappfond
1 January 2026 - 31 December 2026
Children with congenital heart disease, longitudinal neurodevelopment during their first years of life
Promobilia
1 January 2025 - 31 December 2026
Children with congenital heart disease, longitudinal neurodevelopment thier first years of life
The Swedish Heartchild Foundation
1 January 2025
Long-term follow up of neurodevelopment in children with congenital heart disease
The DAMP foundation at the Karolinska University Hospital
1 October 2024
Queen Silvia's Jubilee Fund
Drottning Silvias Jubileumsfond
1 December 2012
ST-forskartjänst
Karolinska Institutet and Stockholm Regions research council
31 May 2010 - 31 December 2014
KID-medel
Karolinska Institutet
1 May 2009

Employments

Affiliated to Research, Department of Women's and Children's Health, Karolinska Institutet, 2025-2027

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Women's and Children's Health, Karolinska Institutet, 2014
University Medical Degree, Karolinska Institutet, 2007

Committee work

Chair, Swedish Pediatric Cardiology Society, 2026-
Member, SWEDCON, 2025-
Member, Swedish Pediatric Cardiology Society, 2024-2026

News from KI

Events from KI